Alpha 1-Antitrypsin Clinical Trials in Birmingham, Alabama
5 recruitingBirmingham, Alabama
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Alpha 1-Antitrypsin Deficiency
Grifols Therapeutics LLC40 enrolled19 locationsNCT07555483
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Alpha 1-Antitrypsin Deficiency
Beam Therapeutics Inc.106 enrolled11 locationsNCT06389877
Recruiting
PiMZ Longitudinal Cohort (PiMZ Logic)
Alpha 1-Antitrypsin DeficiencyEmphysema or COPD
Columbia University80 enrolled5 locationsNCT06505603
Recruiting
Phase 4
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
COPDAlpha 1-AntitrypsinAntibody Deficiency
University of Alabama at Birmingham30 enrolled1 locationNCT07135427
Recruiting
Phase 2
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
EmphysemaAlpha 1-Antitrypsin Deficiency
Sanofi185 enrolled40 locationsNCT05897424